Strategic Solution Architecture • Muhrat Al Marasim
Market Access & Strategic Registration.
الوصول إلى الأسواق والتسجيل الاستراتيجي
Unlocking Market Velocity Across Saudi Arabia and the Gulf Cooperation Council
Executive Framework
Strategic overview and institutional delivery.
Achieve compliant, predictable market entry. Muhrat Al Marasim bridges foreign medical manufacturers with national regulators (SFDA, UAE MoHAP, NHRA Bahrain, MoH Kuwait). We engineer the optimal registration pathway to minimize time-to-market while safeguarding intellectual property.
Strategic Solution Pillars
Regulatory Gap Analysis & Roadmap
Thorough pre-submission auditing of technical files, labeling, and clinical data against latest Saudi MDS standards.
Classification Matrix Optimization
Accurately categorizing device risk profiles to prevent over-classification and costly administrative re-reviews.
Direct Agency Advocacy
Dedicated liaison officers managing daily interactions with SFDA review panels and scientific committees.
Post-Approval Lifecycle Maintenance
Continuous change-control oversight, license renewals, and variation filings across multi-year cycles.
Measurable Corporate Outcomes
Over 98% first-pass review acceptance rate with SFDA
Average 40% reduction in regulatory turnaround cycle
Full ownership and control of your marketing licenses
Operational Execution Stepper
Interactive StagesDossier Screening
We audit existing CE MDR / US FDA 510(k)/PMA dossiers against Saudi specific requirements.
Solution Proposal Blueprint
Configure Engagement Terms
Tailor the operational scope for Market Access & Strategic Registration: